메뉴 건너뛰기




Volumn 53, Issue SUPPL. 3, 2000, Pages 25-29

Selective oestrogen receptor modulators

Author keywords

Breast cancer; Cardiovascular disease; Cognitive function; Endometrium; Oestrogen agonists; Oestrogen antagonists; Oestrogen receptor; Osteoporosis; Selective oestrogen receptor modulators; Venous thromboembolism

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; TRIACYLGLYCEROL;

EID: 0033818343     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000023528     Document Type: Conference Paper
Times cited : (51)

References (15)
  • 1
    • 0033305454 scopus 로고    scopus 로고
    • Selective estrogen receptor modulators: Clinical spectrum
    • Cosman F, Lindsay R: Selective estrogen receptor modulators: Clinical spectrum. Endocr Rev 1999;20:418-434.
    • (1999) Endocr Rev , vol.20 , pp. 418-434
    • Cosman, F.1    Lindsay, R.2
  • 2
  • 3
    • 0033304703 scopus 로고    scopus 로고
    • Tamoxifen, raloxifene, and the prevention of breast cancer
    • Jordan VC, Morrow M: Tamoxifen, raloxifene, and the prevention of breast cancer. Endocr Rev 1999;20:253-278.
    • (1999) Endocr Rev , vol.20 , pp. 253-278
    • Jordan, V.C.1    Morrow, M.2
  • 5
    • 0032508294 scopus 로고    scopus 로고
    • Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital Tamoxifen Randomised Chemoprevention Trial
    • Powles T, Ecles R, Ashley S, Easton D, Chang J, Dowsett M, Tidy A, Viggers J, Davey J: Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital Tamoxifen Randomised Chemoprevention Trial. Lancet 1998;352:98-101.
    • (1998) Lancet , vol.352 , pp. 98-101
    • Powles, T.1    Ecles, R.2    Ashley, S.3    Easton, D.4    Chang, J.5    Dowsett, M.6    Tidy, A.7    Viggers, J.8    Davey, J.9
  • 6
    • 0032508293 scopus 로고    scopus 로고
    • Prevention of breast cancer with tamoxifen: Preliminary findings from the Italian randomised trial among hysterectomised women
    • Veronesi U, Maisonneuve P, Costa A, Sacchini V. Maltoni C, Robertson C, Rotmensz N, Boyle P: Prevention of breast cancer with tamoxifen: Preliminary findings from the Italian randomised trial among hysterectomised women. Lancet 1998;352:352-393.
    • (1998) Lancet , vol.352 , pp. 352-393
    • Veronesi, U.1    Maisonneuve, P.2    Costa, A.3    Sacchini, V.4    Maltoni, C.5    Robertson, C.6    Rotmensz, N.7    Boyle, P.8
  • 7
    • 0000048965 scopus 로고    scopus 로고
    • The potential of SERMs for reducing the risk of coronary heart disease
    • Barrett-Connor E, Cox DA, Anderson PW: The potential of SERMs for reducing the risk of coronary heart disease. Trends Endocrinol Metab 1999;10:320-325.
    • (1999) Trends Endocrinol Metab , vol.10 , pp. 320-325
    • Barrett-Connor, E.1    Cox, D.A.2    Anderson, P.W.3
  • 10
    • 0031797494 scopus 로고    scopus 로고
    • Raloxifene induces neurite outgrowth in estrogen receptor positive PC12 cells
    • Nilsen J, Mor G, Naftolin F: Raloxifene induces neurite outgrowth in estrogen receptor positive PC12 cells. Menopause 1998;5:211-216.
    • (1998) Menopause , vol.5 , pp. 211-216
    • Nilsen, J.1    Mor, G.2    Naftolin, F.3
  • 11
    • 0032928469 scopus 로고    scopus 로고
    • Raloxifene hydrochloride, a selective estrogen receptor modulator: Safety assessment of effects on cognitive function and mood in postmenopausal women
    • Nickelsen T, Lufkin EG, Riggs BL, Cox DA, Crook TH: Raloxifene hydrochloride, a selective estrogen receptor modulator: Safety assessment of effects on cognitive function and mood in postmenopausal women. Psychoneuroendocrinology 1999;24:115-128.
    • (1999) Psychoneuroendocrinology , vol.24 , pp. 115-128
    • Nickelsen, T.1    Lufkin, E.G.2    Riggs, B.L.3    Cox, D.A.4    Crook, T.H.5
  • 12
    • 0000661662 scopus 로고    scopus 로고
    • The molecular pharmacology of SERMs
    • McDonnell DP: The molecular pharmacology of SERMs. Trends Endocrinol Metab 1999;10: 301-311.
    • (1999) Trends Endocrinol Metab , vol.10 , pp. 301-311
    • McDonnell, D.P.1
  • 14
    • 0033304509 scopus 로고    scopus 로고
    • Estrogen activity and novel tissue cell activity of delta-8,9-dehydroestrone sulfate in post-menopausal women
    • Baracat E, Haidar M, Lopez FJ, Pickar J, Dey M, Negro-Vilar A: Estrogen activity and novel tissue cell activity of delta-8,9-dehydroestrone sulfate in post-menopausal women. J Clin Endocrinol Metab 1999;84:220-227.
    • (1999) J Clin Endocrinol Metab , vol.84 , pp. 220-227
    • Baracat, E.1    Haidar, M.2    Lopez, F.J.3    Pickar, J.4    Dey, M.5    Negro-Vilar, A.6
  • 15
    • 0025359604 scopus 로고
    • In vitro evaluation of estrogenic estrogen antagonistic and progestogenic effects of a steroidal drug (ORG OD14) and its metabolites on human endometrium
    • Markiewicz L, Gurpide E: In vitro evaluation of estrogenic estrogen antagonistic and progestogenic effects of a steroidal drug (ORG OD14) and its metabolites on human endometrium. J Steroid Biochem 1991;35:535-541.
    • (1991) J Steroid Biochem , vol.35 , pp. 535-541
    • Markiewicz, L.1    Gurpide, E.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.